Table 1

Clinical data at baseline

Erythropoietin (N=26)Placebo (N=24)
nSummarynSummary
Maternal age, years2623.7±4.32423.8±4.4
Primigravida2615 (58%)2412 (50%)
Maternal diabetes260 (0%240 (0%)
Hypertension261 (3.8%)248 (33.3%)
Anaemia262 (7.7%)241 (4.2%)
Thyroid problems262 (7.7%)243 (12.5%)
Prolonged rupture of membranes >24 hours262 (8%)241 (4%)
Reduced fetal movements263 (12%)233 (13%)
Intrapartum sentinel events261 (4%)244 (9.5%)
Mode of delivery2624
Instrumental delivery2 (8%)1 (4%)
Elective caesarean delivery1 (4%)0 (0%)
Emergency caesarean delivery3 (12%)7 (29%)
Place of delivery2624
Inborn22 (85%)21 (87%)
Outborn4 (15%)3 (13%)
Cord blood or pH within 1 hour of birth76.91±0.2996.96±0.07
Male sex2616 (62%)2421 (88%)
Apgar score at 5 min235 (4–6)245 (3–5)
Apgar score at 10 min196 (5–6)186 (5–6)
Birth weight, g262766±471242884±572
Birth weight <2 SD267 (27%)245 (21%)
Gestation, weeks2638.9±1.12438.5±1.4
Head circumference, cm2633.6±1.52433.3±1.7
Head circumference <2 SD262 (8%)243 (13%)
Endotracheal ventilation at birth2623 (88%)2421 (88%)
Age at admission to NICU, min2625 (15–35)2425 (20–33)
Stage of encephalopathy at randomisation2624
Moderate encephalopathy23 (88%)22 (92%)
Severe encephalopathy3 (12%)2 (8%)
Seizures at randomisation*269 (34.6%)248 (33.3%)
Age at first dose of the intervention (hours)264.4±1.2244.1±1.0
  • Summary statistics are mean±SD, median (IQR) or number (percentage).

  • *Level 1 (definite), 2 (probable) or 3 seizures (possible) as per the updated International League against Epilepsy neonatal seizure task force classification.26

  • NICU, neonatal intensive care unit.